Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model
Investigative Ophthalmology & Visual Science2003Vol. 44(10), pp. 4357–4357
Citations Over TimeTop 10% of 2003 papers
Keith R. Martin, Harry A. Quigley, Donald J. Zack, Hana Levkovitch-Verbin, Jennifer L. Kielczewski, Danielle Valenta, Lisa A. Baumrind, Mary Ellen Pease, Ronald L. Klein, William W. Hauswirth
Abstract
Overexpression of the BDNF gene protects RGC as estimated by axon counts in a rat glaucoma model, further supporting the potential feasibility of neurotrophic therapy as a complement to the lowering of IOP in the treatment of glaucoma.
Related Papers
- → The trabecular meshwork: Structure, function and clinical implications. A review of the literature(2020)134 cited
- → Focus on molecular events in the anterior chamber leading to glaucoma(2013)61 cited
- Hyaluronan in the human trabecular meshwork.(1997)
- [Morphopathological changes in glaucoma-induced trabecular meshwork].(2012)
- Ultrastuctural changes of trabecular meshwork after polythyleneimie perfusion in the rat eye(2003)